HANS MOEBIUS - 13 Oct 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Chief Medical Officer
Signature
/s/ Glenna Mileson, Attorney-in-Fact for Hans Moebius
Issuer symbol
ATHA
Transactions as of
13 Oct 2022
Net transactions value
+$10,639
Form type
4
Filing time
17 Oct 2022, 18:06:59 UTC
Previous filing
30 Jun 2022
Next filing
17 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Options Exercise $10,639 +7,881 +15% $1.35 60,836 13 Oct 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Options Exercise $0 -7,881 -50% $0.000000 7,882 13 Oct 2022 Common Stock 7,881 $1.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option vested on June 1, 2020 and one-fourth of the shares subject to the option vest on each year thereafter.